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ABSTRACT
Background: The Maldives has the highest prevalence of thalassemia in the world. However, there is little research done on 
the psychosocial aspects of this illness.
Objectives: This study aimed to examine health related quality of life (HRQOL) among adolescents with beta-thalassemia 
major attending the National Thalassemia and Other Hemoglobinopathies Centre (NTC), Maldives Blood Services, Maldives. 
Thus, appropriate recommendation could be proposed.
Methods: A total of 81 adolescents (mean age 15.7 years) with beta-thalassemia major were engaged. HRQOL was assessed 
using the Pediatric Quality of Life Inventory (PedsQL). Other relevant information was gathered through interview or medical 
record.
Results: The HRQOL was reduced. The mean for physical, emotional, social, school and psychosocial HRQOL was 80.50, 
72.30, 88.18, 76.44, and 78.96, respectively. The total HRQOL was 79.50 and this was lower in females (75.29) compared to males 
(83.29). Ferritin levels of 1,001-2,499 μg/l and > 2,500 μg/l were noted in 34.2% and 53.9%, respectively. Good compliance was 
reported in 55% of participants. 
Conclusions: Adolescents with beta-thalassemia major in the Maldives have reduced HRQOL. The high ferritin level could 
reduce the HRQOL and hence an attempt should be made towards lowering ferritin and improving compliance to chelation 
treatments. The gender difference in HRQOL signifies the need for more attention to the female patients and for areas of 
improvement to be explored.
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INTRODUCTION
The Republic of Maldives is an island nation of 350,000 people 
located in the lndian Ocean. It consists of 1900 islands, of which 200 
are inhabited. It has one of the highest incidences of thalassemia and has 
the world's highest concentration of carriers at 16-18% of the popula-
tion1) thought to be due to prevalent consanguineous marriages in the 
past2). A total of 670 cases have been registered in the National 
Thalassemia and Other Hemoglobinopathies Centre. It is estimated that 
more than 30% of the population has been screened to date and the high 
percentage of carriers lead to 1 in every 120 child being born is a thalas-
semia major child3). Poor uptake of screening for the condition is one of 
the main reasons for this high number of new cases4).
The Maldivian government identified thalassemia as a national 
problem in the early 1990s, and took initiative involving awareness, 
education, the prevention and treatment programs.4) Though thalassemia 
has been identified as an issue of national concern, the infrastructure 
still lacks the psychological support this group of adolescents need. The 
lack of awareness of this important aspect is highlighted by a number of 
patients as well as family members who were noted to have psychologi-
cal and coping issues, among those met at the daycare centre and the 
NTC institute. Of note was the unintentional omission of this aspect of 
the disease in any of the support booklets or meetings carried out.
Beta-thalassemia major patients require regular blood transfusions 
which lead to iron overload and its complications. In addition, chronic 
hypoxia due to anemia further increases the toxicity of iron deposition 
on various organs.5) Studies have found that high levels of ferritin are 
associated with diabetes mellitus, thyroid and parathyroid disorders as 
well as hypogonadism, with diabetes being the most common6-9). Certain 
complications, especially those related to growth and other metabolic 
changes like delayed menses, has a negative impact on the thalassemia 
children. It has been highlighted that children often endured teasing due 
to their short-stature, and facies as well as "dark" skin colour leading to 
lower self-esteem, feeling stressed up and anxious10). 
Most studies have highlighted that adherence to subcutaneous iron 
chelation therapy was poor and the reasons were side effects, finding it 
difficult and burdensome as well as not wanting to do it10). Other studies 
have found older age, age at the start of treatment and emotional distress 
to be associated with low levels of adherence11). Chronic illness and its 
treatment are associated with lower health related quality of life 
(HRQOL)12). Similarly, studies had demonstrated HRQOL is significant-
ly affected in children with beta-thalassemia major on regular transfu-
sion across all age groups, gender and socio-economic classes and also 
in their caregivers13-16). Thus, improving on patients and maternal educa-
tion is crucial as these factors are recognized as independent predictor 
of better HRQOL17). 
At present the Maldives has a good program in place for the medi-
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cal management of thalassemia. However the psychosocial aspects of 
the condition are not given much weightage. No similar study has been 
conducted in the country, and hence this study is hoped to provide a 
framework for further research, as well as push towards integration of 
psychological support into the program. With this study the authors 
hope to make a difference towards improving these children's lives, by 
submitting a recommendation based on the findings of the study to the 
local authorities. The study was done with the, intention of stressing the 
importance of the integration of psychosocial support into the current 
treatment program.
METHODS
The research was approved by Human Research Ethic Committee, 
USM and Research Committee, Ministry of Health Maldives. This 
cross-sectional study was conducted from March to May 2013 at the 
National Thalassemia and Other Haemoglobinopathies Center (NTC), 
Maldives Blood Services, Maldives. This centre functions as the nation-
al referral centre for those suspected or diagnosed with thalassemia, and 
all thalassemia patients need to be registered here. As of August 2014, a 
cumulative total of 803 thalassemia patients were registered and a total 
of 563 were living1).
The inclusion criteria were; 1) subjects who had been diagnosed 
with beta-thalassemia major, and was on regular follow-up under NTC, 
2) undergoing regular blood transfusion at NTC, 3) adolescents age 10 
to 19 years, and 4) able to comprehend English. The exclusion criteria 
were; 1) had been diagnosed with a psychiatric disorder, 2) family histo-
ry of mental illness, as this could contribute to emotional distress due to 
genetic loading and stressful surrounding, 3) patients positive for human 
immune-deficiency virus.
All patients who fulfilled the criteria during the study period were 
included after obtaining an informed consent which was available in 
both English and Dhivehi (national Maldivian language). The question-
naires were given in an envelope, which they were required to fill up 
and put back in the envelope and seal. The questionnaires were filled up 
while they were getting their blood transfusion in a cubical with ade-
quate privacy. For those who just came for consultation, they were 
given a private room to sit and fill in the questionnaires. Medical 
records were referred to gather clinical information such as hemoglobin 
and ferritin level.
The Pediatric Quality of Life Inventory (PedsQL) is 23-item ques-
tionnaire to measure health-related quality of life (HRQOL) in healthy 
children, adolescents and those with acute and chronic health condi-
tions. It comprises 4 multidimensional scales; physical (8 items), emo-
tional (5 items), social (5 items), and school functioning (5 items). 
Scores comprise of total (23 items), physical Health Summary Score 
(HSS) (8 items) and psychosocial HSS (15 items). Higher PedsQL 
scores reflect higher HRQOL. The scale is valid and reliable with an 
internal consistency 0.88 in child self-report and 0.90 for the parent 
proxy-report18).
Descriptive statistical analyses were performed for socio-demo-
graphic and clinical characteristic using Statistical Packages for Social 
Sciences (SPSS) version 19 software. 
RESULTS
Ninety patients were approached during the study period. A total of 
81 subjects were analyzed after exclusion of 9 patients due to reasons 
such as refusal, inability to understand English, and not returning or 
completing the questionnaires.
The sample consists of 56.8% female, mean age 15.7 years with 
majority in older age group. Majority of the subjects were schooling 
(73.4%). Only a few subjects pursued their studies beyond 10th stan-
dard, or their London Ordinary levels. In term of academic perfor-
mance, majority of them (56.5%) obtained an average result, which was 
classified either a B or C grades, while 27.5% obtained an A grade or 
good result and 15.9% obtained a poor result which was categorized as 
D and below. Twelve subjects did not indicate the last result they 
obtained.
The parental characteristics showed that the majority of parents 
were married (75.3%). The rest of the subjects had a single parent of 
Table 1. Socio-demographic characteristics of subjects (N = 81)
Variables n (%)
Gender
Male 35 (43.2)
Female 46 (56.8)
Age (years)
10-11 5 (6.2)
12-13 14 (17.3)
14-16 29 (35.8)
17-19 33 (40.7)
Schooling/occupational status
Schooling 58 (73.4)
Working 14 (17.7)
Unemployed 7 (8.9)
Number of siblings
None 9 (11.1)
1-2 44 (54.3)
3-5 23 (28.4)
> 5 5 (6.2)
Siblings with thalassemia
No 59 (72.8)
Yes 22 (27.2)
Academic performance
Good 19 (27.5)
Average 39 (56.5)
Low 11 (16.0)
Age of diagnosis
0-12 month 51 (75.0)
1-2 years 12 (17.6)
> 2 years 5 (7.4)
Chelation
None 6 (8.7)
Oral 21 (30.4)
Injectable 16 (23.1)
Both 26 (37.7)
Blood transfusion
Once a week 12 (15.2)
Once every 2 weeks 44 (55.7)
Once every 4 weeks 21 (26.6)
Once in > 4 weeks 2 (2.5)
Hemoglobin level (gm%)
6-7 13 (16.0)
8-9 60 (74.1)
> 9 8 (9.9)
Ferritin level
Normal (≤ 1,000 μg/l) 9 (11.8)
High (1,001-2,499 μg/l) 26 (34.2)
Very high (≥ 2,500 μg/l) 41 (53.9)
Bone marrow transplant
No 75 (92.6)
Yes  6 (7.4)
Table 2. Quality of life of in 81 adolescents (age 10-19) with 
beta-thalassemia major in the Maldives
 Mean (95% CI)
Physical functioning 80.50 (76.42, 84.57)
Emotional functioning 72.30 (67.23, 77.32)
Social functioning 88.18 (84.23,92.14)
School functioning 76.44 (71.66, 81.21)
Psychosocial functioning 78.96 (75.04, 82.88)
Total functioning 79.50 (75.84, 83.15)
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which 16% divorced, 6.2% separated and 2.5% widowed. This is differ-
ent from the national data, as the Maldives has one of the highest rates 
of divorce at 49%19).
The education level of mothers was mostly at secondary level 
(53.1%), followed by 39.5% primary and 7.4% tertiary level. In con-
trast, most fathers had an educational level of primary or below (46.8%) 
and held non-professional jobs (84.9%). The remaining 41.8% and 
11.4% had secondary or tertiary level of education, respectively. 
National statistics show a male to female ratio of 0.9 in primary educa-
tion in 1999-2011, a 1.2 ratio in secondary education from 1999-2000 
and a ratio of 1.9 in 2003 which had fallen to 0.8 in tertiary education19).
Almost two thirds (65.4%) of the mothers were housewives and 
among those who held jobs, 27.2% had non-professional jobs and only 
7.4% had professional jobs. Amongst the fathers, 11% had a profession-
al jobs, while 4,1% were unemployed. The Maldives has an unemploy-
ment rate of more than one in four economically active young being 
unemployed in general. Unemployment rates among female is 3 times 
higher than male.
About three quarters (75.6%) of them were diagnosed before 1 year 
of age, and only 7.4% being diagnosed after 2 years of age. Most of the 
subjects received blood transfusion once in every 2 weeks (55.7%), fol-
lowed by 26.6% in every 4 weeks, 15.2% every week, and 2.6% once a 
month.
More than a third (37.7%) of subjects was on both oral and inject-
able chelator, whereas 30.4% and 23.2% were on oral or subcutaneous 
deferoxamine alone, respectively. It should be noted 7.4% were not on 
any chelator and this might be the 6 patients who had undergone bone 
marrow transplant.
The mean hemoglobin (Hb) level was 8.35 (SD 0.95). 42% of sub-
jects had a hemoglobin level of 9 gm%, with another 32.1% having an 
Hb of 8 gm%. Only 1 participant had an Hb of 11, and another 2 had an 
Hb of 6 gm%.
The mean ferritin level was 3,339.6 μg/l ranging from 400 to 13,000 
μg/l. Due to the vast difference in the range, the ferritin levels were cat-
egorized into normal (≤ 1,000 μg/l), high (1,001-2499 μg/l), and very 
high (≥ 2,500 μg/l) level. Majority of patients had a ferritin levels in the 
high category (53.9%), and only 11.8% patient was in the normal cate-
gory.
Almost two thirds (63%) of patients claimed they did not have any 
medical complications. Amongst the one third (37%) with complica-
tions, 81.5% and 17.3% had liver-related or hormone-related complica-
tions. The less common complications were related to infection (7.4%) 
and spleen (6.2%). 
Subjects had a mean number of 1.2 admissions to hospital for rea-
sons other than blood transfusion since their diagnosis. 35.8% had no 
admission while 23.5% had 2 admissions. The highest number of admis-
sion was 10 in one (1.2%) patient.
Most patients (55.7%) claimed they were always compliant, while 
the rest claimed to be compliant sometimes, rarely or not at all at 29.1%, 
7.6% and 7.6%, respectively.
The mean level of physical, emotional, social and school function-
ing was 80.50, 72.30, 88.18 and 76.44, respectively. The mean level for 
subtotal psychosocial HSS and total functioning was 78.96 and 79.50, 
respectively. The emotional functioning was lowest, while the social 
functioning was highest in this study sample.
DISCUSSION
The World Health Organization Quality of Life Assessment 
(WHOQOL) group defines Quality of Life (QOL) as an individual's per-
ception of their position in life, in the context of culture and value sys-
tems in which they live and in relation to their goals, expectations, stan-
dards and concerns20). This definition by the work group shows that 
quality of life is deeply intertwined with culture and religion, as well as 
variety of other factors, which can contribute to psychological distress 
in patients living with beta-thalassemia major.
The HRQOL in this study was comparable to a similar study con-
ducted in Thailand using the same scale, with 2-8 points difference in 
most domains21). Like the current study, the domain with the highest 
score was social functioning and lowest was that of emotional function-
ing. Similar impairment in emotional functioning has also been reported 
in a study conducted in the United States22). 
The current study showed that the HRQOL of this group was com-
parable to the levels present in healthy controls in Malaysia23). However, 
the findings were consistent with the Thai study21). Similar results could 
possibly mean that the Thai population was more similar to that of the 
current population in term of the care they receive and the life experi-
ences. Like the Maldives, Thailand also considers thalassemia a public 
health problem and has been running several preventive programs since 
the early 1990s.
A possible explanation for the discordance between the Maldivian 
and Malaysian thalassemia group could be that the study was conducted 
one centre in the capital. The control population came from an urban 
area with hectic lifestyle, which involved travelling and long hours at 
school and tuitions. Life in the Maldives is different in this sense, espe-
cially as Malé, which is the capital is only 3 square km. This removes a 
lot of hassle involved in logistics and allows children to spend more 
time at home. In a study,24) longer clinic admission was a significant 
determinant of reduced physical health quality of life. Another possible 
explanation for this could be the national thalassemia program which 
had been in place since 1994, which has increased the awareness among 
the thalassemia population and their family as well as the general pub-
lic.
The mean total functioning scores were different between males 
(83.29) and females (75.29), by nearly 8 points. On further analysis, a 
difference of 10 points was found in the level of physical and psychoso-
cial functioning between the genders as well. This difference was fur-
ther analyzed using the t-test, which showed that a significant mean dif-
ference existed between males and females in both total and psychoso-
cial functioning.
Previous studies have also consistently shown that there are lower 
levels of HRQOL amongst girls when compared to boys25). The possible 
explanation for this gender difference might be the presence of emotion-
al distress in more number of female patients, which translate to poorer 
HRQOL when compared to males. Apart from that, restricted social 
roles, culture, low self-esteem, failure in heterosexual relationships, 
could play a major role in how girls perceived their HRQOL26). 
Academic performance was obtained in an attempt to understand 
how much living with thalassemia affected them. The study showed that 
56.5% and 27.5% obtained an average (B or C report) or a good (A 
report) result, respectively. This achievement was comparable to that of 
average adolescents in the United States, as shown in a study where 
59% obtained an average and 31% received mostly A's. In contrast, sev-
eral studies have demonstrated that academic performance of thalas-
semia children was lower than in the normal population23).
In the Maldives, 70% of the thalassemia children and adolescents 
were attending school, whereas in an Indian study more than half were 
not attending school27). Other reasons given for poor academic perfor-
mances in previous studies were being away from school for various 
thalassemia-related issues10,28). The NTC stays open till 9 pm and 
Saturdays as well, which makes it flexible and missing school can be 
avoided. In addition, various awareness campaigns have been run in the 
Maldives, stressing on the fact that thalassemia children are no different 
from any other child. Great emphasis has been placed on "normalizing" 
the lives of these children by organization such as Society for Health 
Education (SHE).
While conducting the study, the first author also noticed that most 
children and adolescents came with their books to the daycare centre 
and would complete their homework while getting transfused. On con-
versing with the participants, most of them had ambitions and wanted to 
pursue their studies further, showing that they did not view themselves 
as being any different academically.
Nearly one fourth of the patients were taken care of by a single par-
ent. Parents of thalassemia children experience high psychosocial bur-
den, in term of disease chronicity, treatment modalities, morbidities and 
mortality due to complications10,29). A study in India, similarly reported 
greater psychosocial burden as well as poor overall QOL and perception 
of health in parents of thalassemia children14).
Most of the participants (55.7%), received a transfusion every two 
weeks and half (53.5%) were on injectable chelators. The analysis 
showed that the mean level of ferritin for the study group was 3,339 μg/l. 
A ferritin level of < 1,000 μg/l is recommended by the lron Health 
Alliance, US for those children receiving regular blood transfusion. A 
level above 2,500 μg/l puts the child at risk of cardiac complications. 
Further analysis of the data showed that only 11.8% had ferritin levels 
below the recommended level, whereas 53.9% had levels above 2,500 
μg/l, putting them at high risk for further complications. Low HRQOL is 
associated with high ferritin level30), use of injectable chelator31), and 
complications like cardiac condition, short stature and other metabolic 
conditions32,33).
The first author worked in NTC for a short duration of time, and on 
interviewing the children, some of them justified their reason for 
non-compliance by stating "there was no point', as they were going to 
die anyway. Non-compliance is associated with the use of injectable 
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chelators34), psychosocial issues35), and older age11). In this study, half of 
the subjects used intravenous deferoxamine and age above 15, which 
may account for high level of non-compliance. Older patients had poor-
er social functioning probably because of increased awareness about the 
impact of the disease on finding gainful employment, marriage, and par-
enthood36). 
CONCLUSIONS
Adolescents with beta-thalassemia major in the Maldives have 
reduced HRQOL. The high ferritin level could be associated with lower 
HRQOL and hence an attempt should be made towards lowering ferritin 
and improving compliance to chelation treatments. The gender differ-
ence in HRQOL signifies the need for more attention to the female 
patients and for areas of improvement to be explored.
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